by GlobeNewsWire | Sep 1, 2016 | Globe Newswire
LAGUNA HILLS, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Jul 5, 2016 | Globe Newswire
SILVER SPRING, Md., July 05, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Jun 28, 2016 | Globe Newswire
SILVER SPRING, Md., June 28, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Jun 20, 2016 | Globe Newswire
SILVER SPRING, Md., June 20, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Mar 3, 2016 | Globe Newswire
SILVER SPRING, Md., March 03, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its live-cell encapsulation technology, Cell-in-a-Box®,...